Possibility of extending biopharmaceutics classification system based biowaiver to BCS class IIa drug

Farah Khalid; Syed Muhammad Farid Hassan; Rabia Noor; Kamran Zaheer; Fouzia Hassan; Iyad Naeem Muhammad

doi:10.36721/pjps/32/5/02.09-2019/7240/2065-2073

original articles

Possibility of extending biopharmaceutics classification system based biowaiver to BCS class IIa drug

Farah Khalid, Syed Muhammad Farid Hassan, Rabia Noor, Kamran Zaheer, Fouzia Hassan, Iyad Naeem Muhammad

Vol. 32

Issue 5

Pages 2065-2073

Published 01 Sept 2019

DOI: 10.36721/pjps/32/5/02.09-2019/7240/2065-2073

Authors Abstract Related

Authors & Affiliations

Farah Khalid

Syed Muhammad Farid Hassan

Rabia Noor

Kamran Zaheer

Fouzia Hassan

Iyad Naeem Muhammad

Abstract

Biowaiver studies have been performed to assess the bioequivalence of two drug products.

Keywords

Biowaiver

BCS

ibuprofen

bootstrap

bioequivalence

Metrics

PlumX Metrics

original articles

Possibility of extending biopharmaceutics classification system based biowaiver to BCS class IIa drug

Farah Khalid, Syed Muhammad Farid Hassan, Rabia Noor, Kamran Zaheer, Fouzia Hassan, Iyad Naeem Muhammad

Vol. 32

Issue 5

Pages 2065-2073

Published 01 Sept 2019

DOI: 10.36721/pjps/32/5/02.09-2019/7240/2065-2073

Authors Abstract Related

Authors & Affiliations

Farah Khalid

Syed Muhammad Farid Hassan

Rabia Noor

Kamran Zaheer

Fouzia Hassan

Iyad Naeem Muhammad

Abstract

Biowaiver studies have been performed to assess the bioequivalence of two drug products.

Keywords

Biowaiver

BCS

ibuprofen

bootstrap

bioequivalence

Metrics

PlumX Metrics

Possibility of extending biopharmaceutics classification system based biowaiver to BCS class IIa drug

Authors & Affiliations

Abstract

Keywords

Metrics

Indexed & Abstracted in Leading Databases

Possibility of extending biopharmaceutics classification system based biowaiver to BCS class IIa drug

Authors & Affiliations

Abstract

Keywords

Metrics